Evidence map›Paper›PMID 25149315›Full record

ArticleBMC infectious diseases2014

Depolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection.

Shruti Bansal, Kusum Harjai, Sanjay Chhibber

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Acta pharmaceutica Sinica. B · 2024
    Review
  8. Article
  9. Article
  10. Isolation and Characterization of the FirstInternational journal of molecular sciences · 2023
    Article
  11. Article
  12. Article
  13. The Specific Capsule Depolymerase of Phage PMK34 SensitizesAntibiotics (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Phage φAB6-Borne Depolymerase CombatsAntibiotics (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Isolation and Characterization of TwoInternational journal of molecular sciences · 2020
    Article
  19. Isolation of Four Lytic Phages InfectingInternational journal of molecular sciences · 2020
    Article
  20. Identification of a NovelFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shruti Bansal
Kusum Harjai
Sanjay ChhibberDepartment of Microbiology, Panjab University, Sector-14, Chandigarh 160014, India. sanjaychhibber8@gmail.com.
Panjab University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPresence of capsule enhances the virulence of bacteria that cause pneumonia, meningitis, cystic fibrosis, dental caries, periodontitis. Capsule is an important virulence factor for Klebsiella pneumoniae and infections due to this pathogen have been associated with high mortality rates. In the present study, use of an Aeromonas punctata derived capsule depolymerase against K. pneumoniae, to reinstate the efficacy of gentamicin during pneumonia and septicemia was investigated.

methodsDepolymerase was administered in mice intraperitoneally (50 μg) alone as well in combination with gentamicin (1.5 mg/kg), 24 h post infection during acute lung infection and 6 h later during septicemia. Bacterial load, neutrophil infiltration and cytokine levels were estimated. The immunogenicity of protein was also studied.

resultsIn comparison to groups treated with gentamicin alone, combination treatment with depolymerase and gentamicin significantly reduced (P < 0.01) bacterial titer in the lungs, liver, kidney, spleen and blood of experimental animals. Highly significant reduction in neutrophil infiltration and levels of pro-inflammatory and anti-inflammatory cytokines was also observed. This indicated an efficient capsule removal by the enzyme, that improved gentamicin efficacy in vivo. Although the enzyme was found to be immunogenic, but no significant reduction in treatment efficacy was observed in the preimmunized as well as naïve mice. In addition, as confirmed through flow cytometry, the hyperimmune sera raised against the enzyme did not neutralize its activity.

conclusionThe results confirm that administration of enzyme 'depolymerase' along with gentamicin not only checked the virulence of K. pneumoniae in vivo but it also increased its susceptibility to gentamicin at a lower concentration. Such a strategy would help to avoid exposure to higher concentration of gentamicin. Moreover, since this decapsulating protein does not possess a lytic activity therefore there would be no chances of development of bacterial resistance against it. Therefore, it should be studied further for its successful inclusion in our prophylactic/therapeutic regimes.

Indexed as

AeromonasAnimalsCytokinesFemaleGentamicinsHumansImmunologic FactorsKlebsiella InfectionsKlebsiella pneumoniaeLungMaleMiceMice, Inbred BALB CNeutrophil InfiltrationPolysaccharide-LyasesSpecific Pathogen-Free OrganismsCytokinesGentamicinsImmunologic FactorsPolysaccharide-Lyases

Identifiers

PMID25149315
PMCPMC4150946
OpenAlexW2132849234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.